Cost-Effectiveness of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Turkey
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2309
https://www.valueinhealthjournal.com/article/S1098-3015(15)04385-5/fulltext
Title :
Cost-Effectiveness of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Turkey
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04385-5&doi=10.1016/j.jval.2015.09.2309
First page :
A645
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1722